New Bedside Heart Procedure Offers Hope for Extreme Preterm Infants
New Bedside Heart Procedure Offers Hope for Extreme Preterm Infants
New Bedside Heart Procedure Offers Hope for Extreme Preterm Infants
A new bedside technique for closing a common heart defect in extreme preterm infants has shown promising results. The method uses ultrasound guidance to seal the patent ductus arteriosus (PDA) without moving fragile newborns to an operating theatre. Early findings suggest it could improve care while cutting risks and costs. The procedure relies on real-time ultrasound imaging to guide the precise placement of closure devices. This allows doctors to monitor the infant’s heart function continuously, reducing the need for general anaesthesia or sedatives. Both are known to pose risks to neurodevelopment in premature babies.
By performing the closure at the bedside, critically ill infants avoid stressful transfers to catheterisation labs or surgical suites. A small-scale study led by Hundscheid, van den Berg, and de Boode in Pediatric Research reported no major complications, reinforcing its safety in early testing. The approach also aligns with broader shifts in neonatal care toward minimally invasive treatments.
Success depends on close teamwork between neonatologists, paediatric cardiologists, and sonographers. Families benefit too, as reduced stress and improved bonding opportunities arise from keeping infants in the neonatal unit. However, the technique currently uses devices not specifically designed for extreme preterm babies, highlighting a need for tailored tools. While initial results are encouraging, larger trials across multiple centres are required before bedside PDA closure becomes standard practice. The method could eventually shorten hospital stays and lower healthcare expenses, but further research must confirm its long-term benefits. For now, the focus remains on refining devices and expanding evidence in broader patient groups.